Clinical trial
Immunological Consequences of Obstructive Sleep Apnea
NCT00214071 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00214071 |
|---|---|
| Title | Immunological Consequences of Obstructive Sleep Apnea |
| Official title | Influence of Obstructive Sleep Apnea on Humoral and Cell-Mediated Vaccine Responses |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Obstructive Sleep Apnea |
| Intervention type | Biological |
| Interventions | Influenza vaccine |
| Enrollment | 30 |
| Start date | Oct 1, 2004 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 5, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: